Figure 3.
Bar chart comparing the prevalence of the 4 phenotypic abnormalities between controls, carriers bearing non-MYBPC3 mutations and carriers bearing the MYBPC3 mutation.
AMVL = anterior mitral valve leaflet; LVESViR = left ventricular end-systolic volume adjusted for age, body surface area and gender; FDMaxApical = maximal apical fractal dimension; MYBPC3 = myosin-binding protein C, cardiac type; NS = not significant.